Abstract
Objective: To evaluate association between biomarkers and outcomes in COVID-19 hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always played an important role in clinical decision making in various infectious diseases. It is crucial to assess the role of biomarkers in evaluating severity of disease and appropriate allocation of resources.
Design and setting: Systematic review and meta-analysis. English full text observational studies describing the laboratory findings and outcomes of COVID-19 hospitalised patients were identified searching PubMed, Web of Science, Scopus, medRxiv using Medical Subject Headings (MeSH) terms COVID-19 OR coronavirus OR SARS-CoV-2 OR 2019-nCoV from 1 December 2019 to 15 August 2020 following Meta-analyses Of Observational Studies in Epidemiology (MOOSE) guidelines.
Participants: Studies having biomarkers, including lymphocyte, platelets, D-dimer, lactate dehydrogenase (LDH), C reactive protein (CRP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, procalcitonin (PCT) and creatine kinase (CK), and describing outcomes were selected with the consensus of three independent reviewers.
Main outcome measures: Composite poor outcomes include intensive care unit admission, oxygen saturation <90%, invasive mechanical ventilation utilisation, severe disease, in-hospital admission and mortality. The OR and 95% CI were obtained and forest plots were created using random-effects models. Publication bias and heterogeneity were assessed by sensitivity analysis.
Results: 32 studies with 10 491 confirmed COVID-19 patients were included. We found that lymphopenia (pooled-OR: 3.33 (95% CI: 2.51-4.41); p<0.00001), thrombocytopenia (2.36 (1.64-3.40); p<0.00001), elevated D-dimer (3.39 (2.66-4.33); p<0.00001), elevated CRP (4.37 (3.37-5.68); p<0.00001), elevated PCT (6.33 (4.24-9.45); p<0.00001), elevated CK (2.42 (1.35-4.32); p=0.003), elevated AST (2.75 (2.30-3.29); p<0.00001), elevated ALT (1.71 (1.32-2.20); p<0.00001), elevated creatinine (2.84 (1.80-4.46); p<0.00001) and LDH (5.48 (3.89-7.71); p<0.00001) were independently associated with higher risk of poor outcomes.
Conclusion: Our study found a significant association between lymphopenia, thrombocytopenia and elevated levels of CRP, PCT, LDH, D-dimer and COVID-19 severity. The results have the potential to be used as an early biomarker to improve the management of COVID-19 patients, by identification of high-risk patients and appropriate allocation of healthcare resources in the pandemic.
Keywords: critical care; evidence-based practice; global health; infectious disease medicine; prognosis.
【저자키워드】 Critical care, Prognosis., evidence-based practice, global health, infectious disease medicine, 【초록키워드】 COVID-19, Meta-analysis, SARS-CoV-2, coronavirus, pandemic, Biomarker, Biomarkers, Infectious diseases, Diseases, Critical care, Mortality, intensive care, Prognosis, Decision making, COVID-19 pandemic, creatine, 2019-nCoV, COVID-19 severity, LDH, systematic review, CRP, D-dimer, procalcitonin, oxygen, Platelets, Infectious disease, outcome, lactate dehydrogenase, heterogeneity, publication bias, observational studies, observational study, evidence-based practice, global health, Laboratory, laboratory findings, lymphopenia, outcomes, lymphocyte, oxygen saturation, management, healthcare, Aspartate aminotransferase, AST, sensitivity analysis, Hospitalised patients, thrombocytopenia, Severity of disease, creatine kinase, resource, Admission, Critical, COVID-19 patients, High-risk patients, association, intensive care unit admission, ALT, Lactate, Invasive mechanical ventilation, creatinine, meta-analyses, severe disease, Composite, COVID-19 patient, alanine aminotransferase, Medical Subject Headings, forest plot, In-hospital, C reactive protein, medical subject heading, Consensus, Web of Science, higher risk, 95% CI, aspartate, clinical decision, Alanine, nCoV, Random-effects models, forest plots, MOOSE, resources, high-risk patient, PCT, independent, English, IMPROVE, selected, evaluate, include, elevated, hospitalised patient, Publication bia, were assessed, 【제목키워드】 COVID-19, outcome,